Citation: | Xue Rui, Hongjun Gao, Yu Zhang, Jiling Xu, Chengtao He, Qiang Fu. RHD haplotype analysis of a D negative cohort[J]. Blood&Genomics, 2023, 7(1): 43-47. doi: 10.46701/BG.2023012022033 |
[1] |
Gao M, Chen Y. The RHD variants in Chinese population[J]. Blood Genom, 2020, 4(1): 31−38. doi: 10.46701/BG2020012020106
|
[2] |
Jackson ME, JM Baker. Hemolytic disease of the fetus and newborn: historical and current state[J]. Clin Lab Med, 2021, 41(1): 133−151. doi: 10.1016/j.cll.2020.10.009
|
[3] |
Avent ND, Reid ME. The Rh blood group system: a review[J]. Blood, 2000, 95(2): 375−387. doi: 10.1182/blood.V95.2.375
|
[4] |
Daniels G. Variants of RhD-current testing and clinical consequences[J]. Br J Haematol, 2013, 161(4): 461−470. doi: 10.1111/bjh.12275
|
[5] |
Miranda MR, Dos Santos TD, Castilho L. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D[J]. Trans Apher Sci, 2021, 60(6): 103235. doi: 10.1016/j.transci.2021.103235
|
[6] |
Ansart-Pirenne H, Asso-Bonnet M, Le Pennec PY, et al. RhD variants in Caucasians: consequences for checking clinically relevant alleles[J]. Transfusion, 2004, 44(9): 1282−1286. doi: 10.1111/j.1537-2995.2004.04063.x
|
[7] |
Krog GR, Clausen FB, Dziegiel MH. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods[J]. Transfusion, 2007, 47(4): 715−722. doi: 10.1111/j.1537-2995.2007.01175.x
|
[8] |
Safic Stanic H, Dogic V, Bingulac-Popovic J, et al. RhD alloimmunization by DEL variant missed in donor testing[J]. Transfusion, 2022, 62(5): 1084−1088. doi: 10.1111/trf.16862
|
[9] |
Flegel, WA. Molecular genetics and clinical applications for RH[J]. Transfus Apher Sci, 2011, 44(1): 81−91. doi: 10.1016/j.transci.2010.12.013
|
[10] |
Floch A, Pirenne F, Barrault A, et al. Insights into anti-D formation in carriers of RhD variants through studies of 3D intraprotein interactions[J]. Transfusion, 2021, 61(4): 1286−1301. doi: 10.1111/trf.16301
|
[11] |
Westhoff CM, Nance S, Lomas-Francis C, et al. Experience with RHD*weak D type 4.0 in the USA[J]. Blood Transfus, 2019, 17(2): 91−93. doi: 10.2450/2018.0114-18
|
[12] |
Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype[J]. Br J Haematol, 2017, 179(1): 10−19. doi: 10.1111/bjh.14757
|
[13] |
Moussa H, Tsochandaridis M, Kacem N, et al. RHD positive among C/E+ and D-negative blood donors in Tunisia[J]. Transfus Clin Biol, 2014, 21(6): 320−323. doi: 10.1016/j.tracli.2014.10.004
|
[14] |
Yin Q, Flegel WA. DEL in China: the D antigen among serologic RhD-negative individuals[J]. J Transl Med, 2021, 19(1): 1−4. doi: 10.1186/s12967-021-03116-6
|
[15] |
Shao CP. Transfusion of RhD-positive blood in "Asia type" DEL recipients[J]. N Engl J Med, 2010, 362(5): 472−473. doi: 10.1056/NEJMc0909552
|
[16] |
Li Q, Hou L, Guo ZH, et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai[J]. Vox Sang, 2009, 97(2): 139−146. doi: 10.1111/j.1423-0410.2009.01181.x
|
[17] |
El Housse H, El Wafi M, Ouabdelmoumene Z, et al. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors[J]. Blood Transfus, 2019, 17(2): 151−156. doi: 10.2450/2018.0153-18
|
[18] |
Sandler SG, Queenan JT. A guide to terminology for Rh immunoprophylaxis[J]. Obstet Gynecol, 2017, 130(3): 633−635. doi: 10.1097/AOG.0000000000002190
|
[19] |
Ye SH, Wu DZ, Wang MN, et al. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an[J]. Blood Transfus, 2014, 12(3): 396−404. doi: 10.2450/2013.0121-13
|
[20] |
Wu F, Liang S, Zhuang NB, et al. A new RHD variant allele caused by an RHD c.1228-1G>C mutation in a Chinese family[J]. Transfusion, 2021, 61(9): E55−E56. doi: 10.1111/trf.16510
|
[21] |
Zhang J, Zeng Y, Wang Y, et al. RHD genotypes in a Chinese cohort of pregnant women[J]. Front Genet, 2021, 12: 752485. doi: 10.3389/fgene.2021.752485
|
[22] |
Gao Y, Meng X, Hu J, et al. Study of RHD genes amongst RhD negative patients in Xuzhou[J]. Minerva Biotecnologica, 2015, 27(4): 211–213.
|
[23] |
Mouro I, Le Van Kim C, Rouillac C, et al. Rearrangements of the blood group RhD gene associated with the DVI category phenotype[J]. Blood, 1994, 83(4): 1129−1135. doi: 10.1182/blood.V83.4.1129.1129
|
[24] |
Chérif-Zahar B, Le Van Kim C, Rouillac C, et al. Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region[J]. Genomics, 1994, 19(1): 68−74. doi: 10.1006/geno.1994.1014
|
[25] |
Ye L, Wang P, Gao H, et al. Partial D phenotypes and genotypes in the Chinese population[J]. Transfusion, 2012, 52(2): 241−246. doi: 10.1111/j.1537-2995.2011.03266.x
|
[26] |
Haer-Wigman L, Veldhuisen B, Jonkers R, et al. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification[J]. Transfusion, 2013, 53(7): 1559−1574. doi: 10.1111/j.1537-2995.2012.03919.x
|
[27] |
Papasavva T, Martin P, Legler TJ, et al. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus[J]. BMC Res Notes, 2016, 9(1): 198. doi: 10.1186/s13104-016-2002-x
|
[28] |
Ji YL, Luo H, Wen JZ, et al. RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay[J]. Vox Sang, 2017, 112(7): 660−670. doi: 10.1111/vox.12554
|
[29] |
He J, Ying Y, Hong X, et al. Molecular basis and zygosity determination of D variants including identification of four novel alleles in Chinese individuals[J]. Transfusion, 2015, 55(1): 137−143. doi: 10.1111/trf.12797
|
[30] |
Shao CP, Maas JH, Su YQ, et al. Molecular background of RhD positive, D-negative, D(el) and weak D phenotypes in Chinese[J]. Vox Sang, 2002, 83(2): 156−161. doi: 10.1046/j.1423-0410.2002.00192.x
|
[31] |
Huang B, Jia S, Wen J, et al. Serological characteristics and genotype analysis of D epitope of blood group in RhD variant individuals in Guangzhou[J]. Chin J Blood Transfusion (in Chinese), 2021, 32(12): 1290−1295. doi: 10.13303/j.cjbt.issn.1004-549x.2021.12.004
|
[32] |
Wen J, Jia S, Liao Z, et al. Molecular genetic analysis of 32 Chinese Guangzhou donors with D variant phenotype[J]. Chin J Blood Transfusion (in Chinese), 2019, 32(2): 154−157. doi: 10.13303/j.cjbt.issn.1004-549x.2019.02.014
|